Gainers

• $Arcturus Therapeutics Ltd(ARCT.US)$ shares rose 38.6% to $66.88 in pre-market trading after the company reported better-than-expected Q2 earnings and also said ARCT-021 will begin multinational placebo-controlled Phase 3 efficacy study funded & sponsored by a global entity.

• $Dynatronics Corp(DYNT.US)$ rose 34.6% to $1.75 in pre-market trading after the company reported strong preliminary sales for the fourth quarter.

• $BioHiTech Global Inc(BHTG.US)$ rose 21.6% to $1.72 in pre-market trading after the company reported strong Q2 sales.

• $Myomo Inc(MYO.US)$ rose 19.5% to $9.38 in pre-market trading after reporting upbeat Q2 results.

• $FISKER INC.(FSR.US)$ rose 12.4% to $16.89 in pre-market trading. Morgan Stanley resumed covered on the stock with a Buy rating and a $40 price target and set its bull-case scenario at $90.

• $Lufax Holding Ltd(LU.US)$ rose 11.6% to $8.35 in pre-market trading after reporting upbeat quarterly earnings.

• $3D Systems Corp(DDD.US)$ shares rose 11.2% to $31.52 in pre-market trading after the company reported better-than-expected results for its second quarter on Monday.

• $AMC Entertainment Holdings Inc(AMC.US)$ rose 10% to $37.18 in pre-market trading after the company reported stronger-than-expected results for its second quarter. The company said it currently has liquidity availability of more than $2 billion. AMC also announced plans to begin accepting apex cryptocurrency Bitcoin as payment for move tickets and concessions by the end of this year.

• $ASTRA SPACE INC(ASTR.US)$ shares rose 9.8% to $12.30 in pre-market trading after the company was awarded Orbital Services Program (OSP)-4 contract by the Space Force.

• $The9 Ltd(NCTY.US)$ shares rose 9.5% to $18.46 in pre-market trading after gaining around 20% on Monday. The9 Limited and KazDigital, a Kazakhstan cryptomining company, recently signed a term sheet on establishment of joint venture.

• $Oramed Pharmaceuticals Inc(ORMP.US)$ shares rose 8.7% to $22.92 in pre-market trading after climbing over 15% on Monday. The company’s partner Premas Biotech recently signed a Licensing deal for particle injectable vaccine technology, with Oravax for commercialization in India.

• $Purple Innovation Inc(PRPL.US)$ rose 8.3% to $26.81 in pre-market trading after the company swung to a profit in the second quarter. The company also issued FY21 sales guidance.

• $SOC Telemed Inc(TLMD.US)$ rose 7.5% to $4.90 in pre-market trading after gaining 7% on Monday.

• $ZK International Group Co Ltd(ZKIN.US)$ shares rose 7.4% to $3.94 in pre-market trading after jumping about 15% on Monday.

• $Ebang International Holdings Inc(EBON.US)$ rose 6.1% to $3.00 in pre-market trading after gaining around 10% on Monday.

• $Calliditas Therapeutics AB(CALT.US)$ rose 5.6% to $31.15 in pre-market trading. The FDA granted Fast Track Designation to Calliditas Therapeutics lead NOX inhibitor candidate setanaxib for primary biliary cholangitis (PBC).

• $Kansas City Southern(KSU.US)$ rose 4.3% to $281.00 in pre-market trading following a report suggesting Canadian Pacific plans a new higher bid for the company, near $300 per share.

Losers

• $MetroMile Inc(MILE.US)$ shares fell 18.7% to $5.67 in pre-market trading after the company reported a wider-than-expected Q2 loss.

• $SmileDirectClub Inc(SDC.US)$ fell 15.8% to $5.64 in pre-market trading after the company reported worse-than-expected Q2 results and issued weak FY21 sales guidance.

• $Fulgent Genetics Inc(FLGT.US)$ shares fell 15.3% to $93.01 in pre-market trading after the company reported worse-than-expected Q2 results. Fulgent Genetics and Helio Health also reported a partnership to commercialize early cancer detection tests.

• $REATA PHARMACEUTICALS INC(RETA.US)$ fell 14.8% to $104.00 in pre-market trading after the company reported Q2 earnings and provided an update on clinical development programs.

• $Washington Prime Group Inc(WPG.US)$ fell 14.3% to $1.44 in pre-market trading after the company reported Q2 earnings results.

• $Waitr Holdings Inc(WTRH.US)$ fell 9.4% to $1.44 in pre-market trading after the company reported downbeat Q2 results. The company also reported the purchase of ProMerchant LLC, Cape Cod Merchant Services LLC and Flow Payments LLC.

• $Senseonics Holdings(SENS.US)$ shares fell 8.6% to $2.97 in pre-market trading after the company reported Q2 earnings results and issued FY21 guidance.

• $Vuzix Corp(VUZI.US)$ fell 8.5% to $12.56 in pre-market trading after the company reported worse-than-expected Q2 results.

• $Aptinyx Inc(APTX.US)$ fell 7.8% to $2.38 in pre-market trading ahead of Q2 results.

• $Liminal Biosciences Inc(LMNL.US)$ fell 6% to $3.43 in pre-market trading. Liminal BioSciences jumped around 28% on Monday as the company said its subsidiary Prometic Biotherapeutics Inc. entered into a definitive agreement to sell its Rare Pediatric Disease Priority Review Voucher for USD105 million.

• $BioCryst Pharmaceuticals Inc(BCRX.US)$ shares fell 5.8% to $16.62 in pre-market trading after the company announced it commenced a public offering of $200 million of common stock and pre-funded warrants.